Experimental data using a glioma cell line which does not express miR-1 but expresses high levels of Pax3 showed that transfecting cells with miR-1 led to reduced levels of both Pax3 transcript and protein at 48 h13. This evidence concerns the gene PAX3 and central nervous system cancer.